Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (4): 306-308.doi: 10.3736/jcim20090402
• Original Clinical Research • Previous Articles Next Articles
[1] | Zhang XY, Xu LY, Wang H, Zhu YZ, Liu Z, Yue WT, Tang JF, Wu W, Liu Z, Wu YH, Zhang CY, Shi YK, Wang MZ, Shi HL, Li MZ, Meng QY, Guo LL, Wang JH, Li XB . The relationship between EGFR mutations and response and prognosis of tyrosine kinase inhibitors in advanced non-small-cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2008,11(2):206-213 |
张新勇, 徐丽艳, 汪惠, 朱允中, 刘喆, 岳文涛, 唐俊舫, 武玮, 刘赞, 吴羽华, 张春彦, 石远凯, 王孟昭, 史鹤玲, 李明智, 孟弃逸, 郭丽丽, 王敬慧, 李雪冰 . EGFR基因突变与酪氨酸激酶抑制剂疗效及预后之间的关系[J]. 中国肺癌杂志, 2008,11(2):206-213 | |
[2] | Liu YF, Guan XX, Chen LB, Chen YT . Study on ERCC1, XPD and XPA polymorphisms for prediction of platinum-based chemotherapy sensitivity in non-small cell lung cancer[J]. Zhonghua Zhong Liu Fang Zhi Za Zhi, 2008,15(17):1285-1288 |
柳艳飞, 管晓翔, 陈龙邦, 陈一天 . ERCC1与XPD和XPA的遗传多态性对非小细胞肺癌铂类化疗敏感性预测的研究[J]. 中华肿瘤防治杂志, 2008,15(17):1285-1288 | |
[3] | Meng FY, Zheng WY, Liu XL, Song LL, Xu B, Zhang Y . Clinical observation of curative effects of imatinib in treatment of 26 cases of chronic myeloid leukemia[J]. Zhonghua Xue Ye Xue Za Zhi, 2004,25(5):314-315 |
孟凡义, 郑维扬, 刘晓力, 宋兰林, 徐兵, 张钰 . 伊马替尼治疗慢性粒细胞白血病26例临床观察[J]. 中华血液学杂志, 2004,25(5):314-315 | |
[4] | Xu WT, Li R . Efficacy of imatinib mesylate in treatment of advanced gastrointestinal stromal tumors[J]. Di Er Jun Yi Da Xue Xue Bao, 2005,26(5):583-584 |
徐文通, 李荣 . 甲磺酸伊马替尼治疗晚期胃肠道恶性间质瘤疗效的初步观察[J]. 第二军医大学学报, 2005,26(5):583-584 | |
[5] |
Ma D . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. Xun Zheng Yi Xue, 2006,6(5):277-280
doi: 10.3969/j.issn.1671-5144.2006.05.007 |
马冬 . 贝伐单抗联合依立替康、氟尿嘧啶/甲酰四氢叶酸对转移性结直肠癌的治疗[J]. 循证医学, 2006,6(5):277-280
doi: 10.3969/j.issn.1671-5144.2006.05.007 |
|
[6] | Wang T, Luo LL . A systematic review of bevacizumab for non-small cell lung cancer[J]. Zhongguo Shi Yong Yi Yao, 2008,3(5):1-2 |
王艇, 罗黎力 . 贝伐单抗治疗晚期非小细胞肺癌的系统评价[J]. 中国实用医药, 2008,3(5):1-2 |
[1] | Wan-jun Guo, Yi Wang, Yu Deng, Lin-yan Cheng, Xin Liu, Ruo-fan Xi, Sheng-jie Zhu, Xin-yi Feng, Liang Hua, Kan Ze, Jian-yong Zhu, Dong-jie Guo, Fu-lun Li. Therapeutic effects of the extract of Sancao Formula, a Chinese herbal compound, on imiquimod-induced psoriasis via cysteine-rich protein 61. Journal of Integrative Medicine, 2022, 20(4): 376-384. |
[2] | Shang-jin Song, Xuan Liu, Qing Ji, Da-zhi Sun, Li-juan Xiu, Jing-yu Xu, Xiao-qiang Yue. Ziyin Huatan Recipe, a Chinese herbal compound, inhibits migration and invasion of gastric cancer by upregulating RUNX3 expression. Journal of Integrative Medicine, 2022, 20(4): 355-364. |
[3] | Marisa Casal. Improving the health and treatment success rates of in vitro fertilization patients with traditional chinese medicine: need for more robust evidence and innovative approaches. Journal of Integrative Medicine, 2022, 20(3): 187-192. |
[4] | Ning Guo, Fei Wu, Mei Wu, Yuan Wang, Qing Lang, Xiao Lin, Yi Feng. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine . Journal of Integrative Medicine, 2022, 20(3): 204-212. |
[5] | Yan-jun Lin, Kun-li Jiao, Bo Liu, Lu Fang, Shu Meng. Antiplatelet and myocardial protective effect of shexiang tongxin dropping pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial. Journal of Integrative Medicine, 2022, 20(2): 126-134. |
[6] | Jia-jia Li, Qing Liang, Guang-chun Sun. Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition. Journal of Integrative Medicine, 2021, 19(6): 469-477. |
[7] | Rui-jin Qiu, Min Li, Jia-yuan Hu, Jing Chen, Hong-cai Shang. Methods for development of a core outcome set for clinical trials integrating traditional Chinese medicine and Western medicine. Journal of Integrative Medicine, 2021, 19(5): 389-394. |
[8] | Mao-xing Pan, Chui-yang Zheng, Yuan-jun Deng, Kai-rui Tang, Huan Nie, Ji-qian Xie, Dong-dong Liu, Gui-fang Tu, Qin-he Yang, Yu-pei Zhang. Hepatic protective effects of Shenling Baizhu powder, a herbal compound, against inflammatory damage via TLR4/NLRP3 signalling pathway in rats with nonalcoholic fatty liver disease . Journal of Integrative Medicine, 2021, 19(5): 428-438. |
[9] | Ning Zhang, Xiao-he Xiao. Integrative medicine in the era of cancer immunotherapy: Challenges and opportunities. Journal of Integrative Medicine, 2021, 19(4): 291-294. |
[10] | Thomas Efferth, An-long Xu, Roxana Damiescu, Mita Banerjee, Norbert W. Paul, David Y.W. Lee. Can eastern wisdom resolve western epidemics? Traditional chinese medicine therapies and the opioid crisis. Journal of Integrative Medicine, 2021, 19(4): 295-299. |
[11] | Si-qi Tang, Yun-liang Wang, Zi-ye Xie, Yang Zhang, Yi Guo, Kang-li Gao, Tang-you Mao, Chun-e Xie, Jun-xiang Li, Xiao-yan Gao. Serum metabolic profiling of traditional Chinese medicine syndromes in patients with diarrhea-predominant irritable bowel syndrome. Journal of Integrative Medicine, 2021, 19(3): 274-281. |
[12] | Miao-yan Shi, Shi-qi Sun, Wei Zhang, Xing Zhang, Gui-hua Xu, Xuan Chen, Zi-jian Su, Xiu-ming Song, Lu-jiong Liu, Yi-bao Zhang, Yi-le Zhang, Meng Sun, Qi Chen, Yan Xue, Hua Lü, Wei-an Yuan, Xiao-rong Chen, Yun-fei Lu. Early therapeutic interventions of traditional Chinese medicine in COVID-19 patients: a retrospective cohort study. Journal of Integrative Medicine, 2021, 19(3): 226-231. |
[13] | Shu-jun Wei, Qing-man He, Qing Zhang, Kang-hua Fu, Ruo-lan Li, Wei Peng, Yong-xiang Gao. Traditional Chinese medicine is a useful and promising alternative strategy for treatment of Sjogren's syndrome: A review. Journal of Integrative Medicine, 2021, 19(3): 191-202. |
[14] | Yi Xia, Lu-shao-bo Shi, Jing-hui Chang, Hua-zhang Miao, Dong Wang. Impact of the COVID-19 pandemic on intention to use traditional Chinese medicine: A cross-sectional study based on the theory of planned behavior. Journal of Integrative Medicine, 2021, 19(3): 219-225. |
[15] | Na Zhi, Qian Mo, Shuo Yang, Yuan-xing Qin, Hao Chen, Zeng-guang Wu, Cai-hong Lan, Jun Zhang, Yin-long Li. Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report. Journal of Integrative Medicine, 2021, 19(2): 185-190. |